Sean Mackay's most recent trade in Standard BioTools Inc was a trade of 23,919 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 28 May 2025 | 23,919 | 819,157 (1%) | 0% | 1.1 | 26,072 | Common Stock |
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 23 May 2025 | 13,217 | 843,076 (1%) | 0% | 0.9 | 12,437 | Common Stock |
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 21 May 2025 | 12,838 | 868,829 (1%) | 0% | 1.0 | 13,223 | Common Stock |
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 21 May 2025 | 12,536 | 856,293 (1%) | 0% | 1.0 | 12,561 | Common Stock |
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 422,500 | 422,500 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 281,667 | 881,667 (1%) | 0% | 0 | Common Stock |